1

Project Background

Project Background

The Saudi Food&Drug Authority (SFDA) is the government agency responsible for the regulation of food, drugs and medical devices in Saudi Arabia, headquartered in Riyadh and reporting directly to the Prime Minister of Saudi Arabia. The main purpose of the SFDA is to regulate, supervise and monitor food, drugs and medical devices, as well as to develop mandatory standards and specifications. The scope of regulation includes human food, pharmaceuticals (including innovative drugs, generic drugs, health products, herbal medicines and cosmetics), medical devices and in vitro diagnostic devices, as well as biological and chemical substances, electronic products, etc. Ensure the safety, effectiveness and quality of these products and protect the public from harmful, low-quality, false claims, counterfeit and useless products.

SPIMACO Group is the first pharmaceutical company to be listed on the Saudi Stock Exchange and has a wide range of businesses covering pharmaceuticals, biotechnology, medical devices and other sectors. The company is committed to research and development, production and sales of high-quality pharmaceutical products to meet the needs of domestic and foreign markets. At the same time, the SPIMACO Group actively participates in international medical cooperation projects to promote the innovation and development of medical technology.

Ajlan Brothers Medical is an important business unit of Ajlan & Bros Holding Group. We focus on providing high-quality medical services and are committed to meeting the diverse medical needs of patients. The company relies on its professional knowledge and experience in the medical field, as well as advanced medical technology and equipment to provide comprehensive and professional medical services to patients, and is committed to becoming one of the world's leading medical service providers.

The Dubai Health Authority (DHA) was established in June 2007 as the strategic health agency of the Emirate of Dubai with the authority to formulate health policies and strategies, the company was established in 1980 under the direction of the late Ruler of Ras al-Khaimah, Sheikh Sakr bin Mohammed al-Qasimi, and since then, Julphar has been providing high quality, innovative and affordable healthcare solutions to families around the world.

The business is focused on three core business units - Julphar Diabetes Solutions, Generic Drugs and Consumer. Our medicines target key therapeutic areas including gastrointestinal tract (GIT), respiratory system, pain management, wounds and scars, anti-infection, anemia, gynecology, dermatology, erectile dysfunction and cardiology.

Hayat Biotech is a global biotechnology company jointly funded by Sinopharm Sinobiology, Sinopharm International and G42 Group of the United Arab Emirates in 2021. The company is positioned in the development and production of human vaccines, animal vaccines, blood products and other businesses.

As the core of Dubai's medical and health industry cluster, it was proposed and built in 2002 by the Vice President and Prime Minister of the UAE, Sheikh Maktoum of Dubai, and is the world's first and most comprehensive medical and health free zone. It is committed to building an industrial development service system integrating traditional medical services, alternative medical services, medical education and research, medical care, vacation and recuperation, with the goal of meeting the medical and health needs of more than 2 billion people living between Europe and East Asia, and building a world-class health care center.

Cleveland Hospital ABU Dhabi is part of Mubadala Health's network of world-class healthcare facilities and is a unique extension of the Cleveland Clinic model of care in the United States. The hospital is specifically designed to address a range of complex and critical care needs unique to residents and communities in the UAE and is committed to providing a high level of medical care to patients.

time

Locations

Registration call